Direkt zum Inhalt
Merck
Alle Fotos(3)

Dokumente

H0252

Sigma-Aldrich

Hydroxylapatit

Type I, buffered aqueous suspension

Synonym(e):

Calciumphosphat-hydroxid, Durapatit, Hydroxyapatit

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(3)

About This Item

Lineare Formel:
3Ca3(PO4)2 · Ca(OH)2
CAS-Nummer:
1306-06-5
Molekulargewicht:
502.31
EG-Nummer:
215-145-7
MDL-Nummer:
MFCD00010904
UNSPSC-Code:
12161700
PubChem Substanz-ID:
24895395
NACRES:
NA.25

Typ

Type I

Qualitätsniveau

200

Form

buffered aqueous suspension

Lagertemp.

2-8°C

SMILES String

[Ca++].[Ca++].[Ca++].[Ca++].O[Ca+].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O

InChI

1S/5Ca.3H3O4P.H2O/c;;;;;3*1-5(2,3)4;/h;;;;;3*(H3,1,2,3,4);1H2/q5*+2;;;;/p-10

InChIKey

XYJRXVWERLGGKC-UHFFFAOYSA-D

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Anwendung

Useful in the purification of proteins and nucleic acids

Verpackung

Package size based on dry weight

Physikalische Form

Suspension in 0.001 M phosphate buffer, pH 6.8; approx. 25% solids

Lagerklassenschlüssel

13 - Non Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Gloves

Choose from one of the most recent versions:

Analysenzertifikate (COA)

Lot/Batch Number
SLBB4937V
069K5304
019K5307
088K5305
016K53071

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

D Mata et al.
Journal of biomedical nanotechnology, 10(5), 725-743 (2014-04-17)
Biomaterials can still be reinvented to become simple and universal bone regeneration solutions. Following this roadmap, a bone graft of carbon nanotube (CNT)/glass/hydroxyapatite (HA) with controlled CNT agglomeration state was designed with multifunctionalities able to stimulate the bone cell phenotype.
Sergio Bertazzo et al.
Nature materials, 12(6), 576-583 (2013-04-23)
The accumulation of calcified material in cardiovascular tissue is thought to involve cytochemical, extracellular matrix and systemic signals; however, its precise composition and nanoscale architecture remain largely unexplored. Using nano-analytical electron microscopy techniques, we examined valves, aortae and coronary arteries
Frank G Lyons et al.
Clinical orthopaedics and related research, 472(4), 1318-1328 (2014-01-05)
Treatment of segmental bone loss remains a major challenge in orthopaedic surgery. Traditional techniques (eg, autograft) and newer techniques (eg, recombinant human bone morphogenetic protein-2 [rhBMP-2]) have well-established performance limitations and safety concerns respectively. Consequently there is an unmet need
Sören Toksvig-Larsen et al.
Acta orthopaedica, 84(3), 314-318 (2013-04-30)
External fixation pins tend to loosen with time, especially from cancellous bone. A coating that releases a bisphosphonate has been shown to improve the fixation of dental implants in humans. We now tested a bisphosphonate coating on steel pins for
H S Alghamdi et al.
Journal of dental research, 92(11), 982-988 (2013-09-24)
Osteoporotic conditions are anticipated to affect the osseointegration of dental implants. This study aimed to evaluate the effect of a radiofrequent magnetron-sputtered calcium phosphate (CaP) coating on dental implant integration upon installment in the femoral condyles of both healthy and
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.